World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-TRC-09000338
Date of registration: 2009-02-23
Prospective Registration: Yes
Primary sponsor: The First Affiliated Hospital of Zhejiang University
Public title: Full dose of RASS blockade versus steroids therapy in patients with IgA nephropathy
Scientific title: Full dose of RASS blockade versus steroids therapy in patients with IgA nephropathy
Date of first enrolment: 2009-04-01
Target sample size: Group A:60;Group B:60;
Recruitment status: Completed
URL:  http://www.chictr.org.cn/showproj.aspx?proj=9193
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Post-market
Countries of recruitment
China
Contacts
Name: Chen Jianghua   
Address:  79 Qingchun Road, Hangzhou, Zhejiang, China 31003
Telephone: +86 0571 87236189
Email: chenjianghua@zju.edu.cn
Affiliation: 
Name: Cheng Jun   
Address:  79 Qingchun Road, Hangzhou, Zhejiang, China 310003
Telephone: +86 0571 87236189
Email: chengjunwood@sohu.com
Affiliation:  Kidney Disease Center of the First Affiliated Hospital of Zhejiang University
Key inclusion & exclusion criteria
Inclusion criteria: 1. biopsy-proven IgA nephropathy;
2. proteinuria (protein, 1.5 to 3 g/d);
3. eGFR>30ml/min/1.75m2;
4. Age 18-70 years;
5 Hypertention or untreated blood pressure >130/80mmHg.

Exclusion criteria: 1. Secondary IgA nephropathy;
2. Pathology-proven crecsentic glomerulonephritis.


Age minimum: 18
Age maximum: 70
Gender: Male
Health Condition(s) or Problem(s) studied
IgA nephropathy
Intervention(s)
Group A:Full dose of RASS blockade (ACEI and ARB blocker);Group B:prednisone ;
Primary Outcome(s)
Concentration of serum creatinin;
Secondary Outcome(s)
Quantitative Urinary protein in 24 hours;
Secondary ID(s)
Source(s) of Monetary Support
Self-financed
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history